EUVIMEDEUVIMED entdecken
Multizentrische Studie

Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt–Jakob disease

Laura Naranjo, Jordi Sarto, Carlos Nos, Daniel Alcolea, Iñigo Rodríguez-Baz, Irene Navalpotro-Gómez, Aída Fernández-Lebrero, Bernat Bertrán-Recasens, María Elena Erro, Ana Lara Pelayo-Negro, Clara Esteve, Susana Fernández und 14 weitere

Journal of Neurology · 2025

DOI: 10.1007/s00415-024-12757-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neurology, 2025. Verfasst von Laura Naranjo und 25 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Biomedical Diagnostic Center, Hospital Clínic de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome, 14-3-3 Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Discrepancies in results between cerebrospinal fluid (CSF) 14-3-3 protein and prion protein detection using real-time quaking-induced conversion (RT-QuIC) might limit the confidence in ante-mortem clinical diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD). We aimed to evaluate the concordance and diagnostic performance of 14-3-3 protein and RT-QuIC in a real clinical practice cohort, and to analyze neuronal/glial damage biomarkers in sCJD patients based on their diagnostic assay results. A retrospective multicentre study was conducted on 157 suspected sCJD patients from 38 Spanish hospitals in a 4-year period. CSF 14-3-3 protein and RT-QuIC were simultaneously evaluated in a single laboratory. A diagnosis of probable sCJD was established in 63 patients (40.1%), of which 12 (19.0%) were ultimately diagnosed with definite sCJD. Forty-one sCJD patients (65.1%) were positive for both 14-3-3 protein and RT-QuIC, 17 (27.0%) isolated positive for RT-QuIC, and 5 (7.9%) isolated positive for 14-3-3 protein. RT-QuIC demonstrated higher sensitivity (92.1%) and specificity (98.9%) compared to 14-3-3 (73.0% and 62.8%) for the diagnosis of sCJD. Isolated RT-QuIC positivity was associated with longer disease duration (median: 10.5 months, IQR: 8.8-15.7), higher frequency of Met/Val cases (75.0%), lower prevalence of periodic sharp-wave complexes (5.9%), and lower levels of GFAP (3967.4 pg/mL), UCH-L1 (2218.1 pg/mL), and t-Tau (228.8 pg/mL) compared to double-positive and isolated 14-3-3-positive patients. In conclusion, CSF RT-QuIC is a highly specific and sensitive biomarker for ante-mortem sCJD diagnosis and should be considered as the preferred CSF ancillary test. Isolated RT-QuIC positivity indicates a less aggressive biological disease in sCJD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Creutzfeldt-Jakob Syndrome14-3-3 ProteinsHumansMaleFemaleMiddle AgedBiomarkersAgedRetrospective StudiesPrion ProteinsAged, 80 and overAdulttau ProteinsDisease ProgressionNeurogliaNeurons

Stichwörter der Autor:innen

14-3-3 proteinDiagnostic performanceNeuronal/glial damage biomarkersReal-time quaking-induced conversionSporadic Creutzfeldt–Jakob disease

Substanzen

14-3-3 ProteinsBiomarkersPrion Proteinstau Proteins

Autor:innen und Institutionen

  • Immunology Department, Biomedical Diagnostic Center, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • General Subdirectorate of Surveillance and Response to Emergencies in Public Health, Department of Public Health in Catalonia, Barcelona, Spain.
  • Sant Pau Memory Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Barcelona, Spain.
  • Cognitive Decline and Movement Disorders Unit, Neurology Department, Hospital del Mar-Hospital del Mar Research Institute, Barcelona, Spain.
  • Neuromuscular Diseases Unit, Neurology Department, Hospital del Mar, Barcelona, Spain.

Zitieren

APA

Naranjo, L., Sarto, J., Nos, C., Alcolea, D., Rodríguez-Baz, I., Navalpotro-Gómez, I., Fernández-Lebrero, A., Bertrán-Recasens, B., Erro, M. E., Pelayo-Negro, A. L., Esteve, C., Fernández, S., Massot-Tarrús, A., Boltes, A., Torrents, A., Guanyabens, N., Palomino-García, A., Egri, N., Lladó, A., …, & Spanish sCJD Study Group (2025). Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt–Jakob disease. Journal of Neurology. https://doi.org/10.1007/s00415-024-12757-8

Vancouver

Naranjo L, Sarto J, Nos C, Alcolea D, Rodríguez-Baz I, Navalpotro-Gómez I, et al. Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt–Jakob disease. Journal of Neurology. 2025. doi:10.1007/s00415-024-12757-8

BibTeX
@article{Naranjo2025,
  author = {Naranjo, Laura and Sarto, Jordi and Nos, Carlos and Alcolea, Daniel and Rodríguez-Baz, Iñigo and Navalpotro-Gómez, Irene and Fernández-Lebrero, Aída and Bertrán-Recasens, Bernat and Erro, María Elena and Pelayo-Negro, Ana Lara and Esteve, Clara and Fernández, Susana and Massot-Tarrús, Andreu and Boltes, Anuncia and Torrents, Albert and Guanyabens, Nicolau and Palomino-García, Alfredo and Egri, Natalia and Lladó, Albert and Balasa, Mircea and Romera, María Antonia and Antón, María Del Carmen and Couso, Rocío Soledad and Sánchez-Valle, Raquel and Ruiz-García, Raquel and Spanish sCJD Study Group, Spanish sCJD Study Group},
  title = {Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt–Jakob disease},
  journal = {Journal of Neurology},
  year = {2025},
  doi = {10.1007/s00415-024-12757-8}
}
Kostenlos starten →